Publications
Alhadj Ali M, Liu YF, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, Heck S, Yang JHM, Tree TIM, Pujol-Autonell I, Yeo L, Baumard LR, Stenson R, Howell A, Clark A, Boult Z, Powrie J, Adams L, Wong FS, Luzio S, Dunseath G, Green K, O'Keefe A, Bayly G, Thorogood N, Andrews R, Leech N, Joseph F, Nair S, Seal S, Cheung H, Beam C, Hills R, Peakman M, Dayan CM. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf7779. doi: 10.1126/scitranslmed.aaf7779. PMID: 28794283
Moser O, Tschakert G, Mueller A, Groeschl W, Pieber TR, Koehler G, Eckstein ML, Bracken RM, Hofmann P. Atypical blood glucose response to continuous and interval exercise in a person with type 1 diabetes: a case report. J Med Case Rep. 2017 Jun 30;11(1):176. doi: 10.1186/s13256-017-1355-7. PMID: 28662684
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17. PMID: 28304224
Thong KY, Yadagiri M, Barnes DJ, Morris DS, Chowdhury TA, Chuah LL, Robinson AM, Bain SC, Adamson KA, Ryder REJ; ABCD Nationwide Dapagliflozin Audit contributors. Clinical risk factors predicting genital fungal infections with sodium-glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit. Prim Care Diabetes. 2017 Jun 29. pii: S1751-9918(17)30092-X. doi: 10.1016/j.pcd.2017.06.004. [Epub ahead of print] PMID: 28669625
Thomas RL, Luzio SD, North RV, Banerjee S, Zekite A, Bunce C, Owens DR. Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015. BMJ Open. 2017 Jul 18;7(7):e015024. doi: 10.1136/bmjopen-2016-015024. PMID: 28720613
Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, Kronenberg-Versteeg D, Eichmann M, Knight RR, Heck S, Powrie J, Bingley PJ, Dayan CM, Miles JJ, Sewell AK, Price DA, Peakman M. β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes. 2015 Mar;64(3):916-25. doi: 10.2337/db14-0332. Epub 2014 Sep 23.PMID: 25249579
Vedhara K, Dawe K, Miles JN, Wetherell MA, Cullum N, Dayan C, Drake N, Price P, Tarlton J, Weinman J, Day A, Campbell R, Reps J, Soria D. Illness Beliefs Predict Mortality in Patients with Diabetic Foot Ulcers. PLoS One. 2016 Apr 20;11(4):e0153315. doi: 10.1371/journal.pone.0153315. eCollection 2016. PMID: 27096609
Dul M, Stefanidou M, Porta P, Serve J, O'Mahony C, Malissen B, Henri S, Levin Y, Kochba E, Wong FS, Dayan C, Coulman SA, Birchall JC. Hydrodynamic gene delivery in human skin using a hollow microneedle device. J Control Release. 2017 Feb 28. pii: S0168-3659(17)30087-1. doi: 10.1016/j.jconrel.2017.02.028. [Epub ahead of print] PMID: 28254630
Owens DR, Landgraf W, Sandow J, Mbanya JC. Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy. European Endocrinology, 2017;13(1):21–5 DOI: https://doi.org/10.17925/EE.2017.13.01.21
Owens DR, Monnier L, Hanefeld M. A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus. Diabetes Obes Metab. 2017 May 4. doi: 10.1111/dom.12998. [Epub ahead of print] Review. PMID: 28474401